New drug development is focused largely on biopharmaceuticals rather than chemicals, which means the resultant drugs tend to be injectable liquids instead of solids. Furthermore, the new drugs are...
By Frances L. DeGrazio, vice president, Marketing & Strategic Business Development, West Bringing a new biological drug to market requires a huge financial commitment and entails risks in every...
By Rick Rys, President, R2 Controls, and Janice Abel, Director, Global Pharmaceutical and Biotech Industries, Invensys Before the U.S. Food and Drug Administration (FDA) released its final guidance...
By Michael Kowolenko, Wyeth Pharmaceuticals Our experience in biopharmaceutical manufacturing spans over three decades and has allowed us to point to measurable successes: record improvements of...
In July, the U.S. Food and Drug Administration issued a final interim rule limiting the types of animal-derived materials that can be used to manufacture animal feed, cosmetics, and food supplements.